Showing results (1-10 of 673) with videos related to
Sort By:
Pageof 68
Cancer Chemotherapy and Pharmacology|March 21, 2007
Challenges for patient selection with VEGF inhibitorsR Longo, G GaspariniThe International Journal of Biological Markers|July 19, 2006
Sequential adjuvant hormone therapy in postmenopausal breast cancer: rationale and clinical resultsR Longo, M R D'Andrea, G GaspariniAnnals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2005
Therapy of breast cancer with molecular targeting agentsG Gasparini, R Longo, F Torino, et al.Critical Reviews in Oncology/Hematology|April 26, 2008
Pancreatic cancer: from molecular signature to target therapyR Longo, F Cacciamani, G Naso, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2007
Integrated therapy of kidney cancerR Longo, M R D'Andrea, R Sarmiento, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|April 16, 2005
Clinical benefit of intermittent administration of imatinib in a patient with metastatic gastrointestinal stromal tumourA Morabito, R Longo, G Carillio, et al.Angiogenesis|August 9, 2003
Anti-angiogenic therapy: rationale, challenges and clinical studiesR Longo, R Sarmiento, M Fanelli, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2005
Gefitinib (ZD1839) combined with weekly epirubicin in patients with metastatic breast cancer: a phase I study with biological correlateG Gasparini, R Sarmiento, S Amici, et al.The International Journal of Biological Markers|February 17, 2017
Remembering Judah Moses FolkmaG GaspariniCritical Reviews in Oncology/Hematology|February 13, 2001
Clinical significance of determination of surrogate markers of angiogenesis in breast cancerG GaspariniPageof 68